For example, Khatri and colleagues reported a mutant MDM2 single-nucleotide polymorphism to be more prevalent in 98 patients with GBM (54.6%) compared to 102 healthy controls (41.2%) (p = 0.0092) [31]. The gene discussed is MDM2; the disease is glioblastoma.